SANUWAVE Health (SNWV) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.11% |
| Dec 31, 2025 | 16.19% |
| Sep 30, 2025 | 3.56% |
| Jun 30, 2025 | -4.87% |
| Mar 31, 2025 | -10.62% |
| Dec 31, 2024 | -9.44% |
| Sep 30, 2024 | -35.24% |
| Jun 30, 2024 | -19.35% |
| Mar 31, 2024 | -24.84% |
| Dec 31, 2023 | -23.74% |
| Sep 30, 2023 | -33.41% |
| Jun 30, 2023 | -33.11% |
| Mar 31, 2023 | -31.01% |
| Dec 31, 2022 | -32.93% |
| Sep 30, 2022 | -31.38% |
| Jun 30, 2022 | -34.11% |
| Mar 31, 2022 | -39.26% |
| Dec 31, 2021 | -41.32% |
| Sep 30, 2021 | -39.36% |
| Jun 30, 2021 | -32.75% |
| Mar 31, 2021 | -25.45% |
| Dec 31, 2020 | -193.97% |
| Sep 30, 2020 | -12.16% |
| Jun 30, 2020 | -28.72% |
| Mar 31, 2020 | -36.05% |
| Dec 31, 2019 | -45.35% |
| Sep 30, 2019 | -99.49% |
| Jun 30, 2019 | -77.49% |
| Mar 31, 2019 | -62.03% |
| Dec 31, 2018 | -20.17% |
| Sep 30, 2018 | -20.89% |
| Jun 30, 2018 | -4.39% |
| Mar 31, 2018 | -4.25% |
| Dec 31, 2017 | -8.67% |
| Sep 30, 2017 | -10.33% |
| Jun 30, 2017 | -13.78% |
| Mar 31, 2017 | -18.55% |
| Dec 31, 2016 | -35.09% |
| Sep 30, 2016 | -79.48% |
| Jun 30, 2016 | -37.19% |
| Dec 31, 2015 | 14.94% |